Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Short Interest Update

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) saw a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 1,550,000 shares, a growth of 261.3% from the November 15th total of 429,000 shares. Currently, 4.5% of the company’s shares are sold short. Based on an average daily volume of 5,300,000 shares, the days-to-cover ratio is currently 0.3 days.

Cardio Diagnostics Stock Up 16.0 %

Shares of CDIO stock traded up $0.19 during trading on Friday, hitting $1.39. 6,139,174 shares of the stock traded hands, compared to its average volume of 2,085,695. Cardio Diagnostics has a 52-week low of $0.19 and a 52-week high of $3.56. The firm’s fifty day moving average price is $0.35 and its 200-day moving average price is $0.42.

Wall Street Analysts Forecast Growth

Separately, Benchmark reissued a “speculative buy” rating and set a $2.00 price target on shares of Cardio Diagnostics in a research report on Tuesday, August 27th.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.